Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 556921 - 556940 out of 557894 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EX10) midostaurin (adm: O) | RYDAPT 25MG CAPSULE | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Mastocytosis | NovartisPharmaceuticalsCorporation |
| USA | (L01EX10) midostaurin (adm: O) | RYDAPT 25MG CAPSULE | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Mastocytosis | NovartisPharmaceuticalsCorporation |
| USA | (L01EX10) midostaurin (adm: O) | RYDAPT 25MG CAPSULE | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Mastocytosis | NovartisPharmaceuticalsCorporation |
| USA | (L01EX10) midostaurin (adm: O) | RYDAPT 25MG CAPSULE | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Mastocytosis | NovartisPharmaceuticalsCorporation |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 20MG/ML SOLN,ORAL | 100ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 20MG/ML SOLN,ORAL | 100ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 20MG/ML SOLN,ORAL | 2x50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 20MG/ML SOLN,ORAL | 2x50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 100MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 100MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 25MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 25MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01FA01) rituximab | RIABNI 100MG INJ | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AmgenUSA,Inc. |
| USA | (L01FA01) rituximab | RIABNI 100MG INJ | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AmgenUSA,Inc. |
| USA | (L01FA01) rituximab | RIABNI 500MG INJ | 50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AmgenUSA,Inc. |
| USA | (L01FA01) rituximab | RIABNI 500MG INJ | 50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AmgenUSA,Inc. |
| USA | (L01FA01) rituximab | RUXIENCE 10MG/ML INJ,VIL,10ML | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis;Pemphigus | PfizerInc. |
| USA | (L01FA01) rituximab | RUXIENCE 10MG/ML INJ,VIL,10ML | 50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis;Pemphigus | PfizerInc. |
| USA | (L01FD01) trastuzumab (adm: P) | TRASTUZUMAB-ANNS 150MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AmgenUSAInc. |
| USA | (L01FD01) trastuzumab (adm: P) | TRASTUZUMAB-ANNS 150MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AmgenUSAInc. |
Pages
